doi: 10.1371/journal.pone.0175794 [DOI] [PMC free article] [PubMed] [Google Scholar] 26.Flattet Y, Garin N, Serratrice J, Perrier A, Stirnemann J, Carballo S
doi: 10.1016/j.cmet.2016.06.009 38 ChenJXuSZhouWWuLWangLLiW
If you're like me, that means you're also seeing hope that the out-of-pocket costs of these medications, which include Ozempic, Zepbound, and Wegovy, will go down in the future as more players enter the field
Diabetes, heart disease, and some types of cancer are among the debilitating and deadly diseases associated with obesity
Metformin in pregnancy study (MiPS): protocol for a systematic review with individual patient data metaanalysis
People who begin obesity treatment with glucagon-like peptide-1 receptor agonists (GLP-1s) and then undergo metabolic and bariatric surgery achieve substantially greater weight loss than with the medications alone, according to new research presented today at the annual meeting of the American Society for Metabolic and Bariatric Surgery (#ASMBS2026)